ゲノミクスの世界市場：ゲノム解析装置、消耗品、シークエンシング、PCR、マイクロアレイ...市場調査レポートについてご紹介

1 Introduction (Page No. – 18)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 22)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Industry Insights
2.2.2.2 Key Data From Primary Sources
2.2.2.3 Key Insights From Primary Sources
2.3 Market Size Estimation Methodology
2.4 Market Forecast Methodology
2.5 Market Data Validation and Triangulation

3 Executive Summary (Page No. – 31)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Growth Strategies

4 Premium Insights (Page No. – 37)
4.1 Global Market Overview
4.2 Global Market, By Technology
4.3 Geographic Analysis of the Market, By End User
4.4 Global Market, By Process
4.5 Geographical Snapshot of the Market

5 Market Overview (Page No. – 42)
5.1 Introduction
5.2 Evolution
5.3 Market Segmentation
5.4 Market Dynamics
5.4.1 Drivers
5.4.1.1 Rising Government Funding and Growth in the Number of Genomics Projects
5.4.1.2 Decreasing Sequencing Costs
5.4.1.3 Growing Application Areas of Genomics
5.4.1.4 Increasing Awareness of Genomics
5.4.1.5 Entry of New Players and Start-Ups in the Genomics Market
5.4.2 Restraints
5.4.2.1 High Cost of Genomic Equipment
5.4.2.2 Privacy Issues Related to Genetic Information
5.4.2.3 Shortage of Trained Professionals
5.4.3 Opportunity
5.4.3.1 Use of Genomics in Specialized/Personalized Medicine
5.4.4 Challenge
5.4.4.1 Secure Storage of Large Volume of Sequenced Data

6 Global Genomics Market, By Product (Page No. – 55)
6.1 Introduction
6.2 Instruments/Systems
6.3 Consumables
6.4 Services

7 Global Genomics Market, By Technology (Page No. – 61)
7.1 Introduction
7.2 Sequencing
7.3 Microarray Technology
7.4 PCR (Polymerase Chain Reaction)
7.5 Nucleic Acid Extraction and Purification
7.6 Other Technologies

8 Global Genomics Market, By Process (Page No. – 68)
8.1 Introduction
8.2 Library Preparation
8.3 Sequencing and Imaging
8.4 Data Analysis

9 Global Genomics Market, By Application (Page No. – 73)
9.1 Introduction
9.2 Diagnostics
9.2.1 Cancer Diagnostics
9.2.2 Monogenic (Mendelian) Disorders
9.2.3 Other Diagnostic Applications
9.2.3.1 Movement Disorders
9.2.3.2 HIV
9.3 Drug Discovery and Development
9.4 Personalized Medicine
9.5 Agriculture & Animal Research
9.6 Other Applications

10 Global Genomics Market, By End User (Page No. – 82)
10.1 Introduction
10.2 Research Centers, Academic Institutes, and Government Institutes
10.3 Hospitals and Clinics
10.4 Pharmaceutical & Biotechnology Companies
10.5 Other End Users

11 Global Genomics Market, By Region (Page No. – 89)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.1.1 Research Grants and Funding By Government Institutes
11.2.1.2 U.S. Precision Medicine Initiative
11.2.1.3 Presence of Top Players Together With Their Collaborations, Investments, and Partnerships
11.2.2 Canada
11.2.2.1 The New Pan-Canadian Program in Canada
11.3 Europe
11.3.1 Conferences and Meetings in Europe
11.3.2 U.K.
11.3.2.1 100,000 Genome Project in Uk
11.3.3 Germany
11.3.3.1 Academic Institutes to Boost the Market in Germany
11.3.4 RoE
11.3.4.1 Turkey to Offer Growth Opportunities
11.4 Asia-Pacific
11.4.1 Players Focus on Improving Their Presence in Asia-Pacific
11.4.2 China
11.4.2.1 Western Partnerships in China Aimed at Improving Healthcare
11.4.2.2 BGI’s Contribution to Market Growth
11.4.3 India
11.4.3.1 Emergence of Local Players in India Backed By Funding From the Government
11.4.4 Japan
11.4.4.1 Collaborations Between Key Global and Local Players
11.4.5 Rest of Asia-Pacific
11.4.5.1 Alliances and Partnerships in the Market to Boost the Australian Market
11.5 Rest of the World (RoW)
11.5.1 Middle East and Africa
11.5.1.1 Saudi Human Genome Project
11.5.2 Latin America
11.5.2.1 Investments in Research and Innovation Centers and Conferences & Workshops in Brazil

12 Competitive Landscape (Page No. – 137)
12.1 Overview
12.2 Market Share Analysis
12.2.1 Illumina, Inc. (U.S.)
12.2.2 Beijing Genomics Institute (China)
12.2.3 Eurofins Genomics (Germany)
12.2.4 Qiagen N.V. (Netherlands)
12.2.5 Thermo Fisher Scientific, Inc. (U.S.)
12.2.6 Agilent Technologies, Inc. (U.S.)
12.2.7 Affymetrix, Inc. (U.S.)
12.2.8 Other Players
12.3 Competitive Situation and Trends
12.3.1 New Product Launches
12.3.2 Agreements, Contracts, Partnerships, and Collaborations
12.3.3 Acquisitions
12.3.4 Expansions
12.3.5 Other Developments

13 Company Profiles (Page No. – 152)
(Overview, Financials, Products & Services, Strategy, & Developments)*
13.1 Introduction
13.2 Thermo Fisher Scientific, Inc.
13.3 Agilent Technologies, Inc.
13.4 Affymetrix, Inc.
13.5 Beijing Genomics Institute (BGI)
13.6 Bio-Rad Laboratories, Inc.
13.7 Cepheid, Inc.
13.8 Eurofins Genomics, Inc. (Subsidiary of Eurofins Scientific Group)
13.9 GE Healthcare
13.10 Illumina, Inc.
13.11 Qiagen N.V.
13.12 Roche Holding AG

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 179)
14.1 Discussion Guide
14.2 Company Developments (2012-2015)
14.2.1 Thermo Fisher Scientific, Inc.
14.2.2 Agilent Technologies, Inc.
14.2.3 Affymetrix, Inc.
14.2.4 Beijing Genomics Institute (BGI)
14.2.5 Bio-Rad Laboratories, Inc
14.2.6 Eurofins Genomics, Inc.
14.2.7 Illumina, Inc.
14.2.8 Qiagen N.V.
14.2.9 Roche Holding AG
14.3 Introducing RT: Real-Time Market Intelligence
14.4 Available Customizations
14.5 Related Reports